[ { "eMeasureId": "CMS117v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-138ff3280ad1", "strata": [ { "description": "DTaP\nChildren with any of the following on or before the child’s second birthday meet criteria:\n- At least four DTaP vaccinations, with different dates of service. Do not count a vaccination administered prior to 42 days after birth.\n- Anaphylaxis due to the diphtheria, tetanus or pertussis vaccine.\n- Encephalitis due to the diphtheria, tetanus or pertussis vaccine.\n\nIPV\nChildren with either of the following on or before the child’s second birthday meet criteria:\n- At least three IPV vaccinations, with different dates of service. Do not count a vaccination administered prior to 42 days after birth.\n- Anaphylaxis due to the IPV vaccine.\n\nMMR\nChildren with any of the following meet criteria:\n- At least one MMR vaccination on or between the child’s first and second birthdays.\n- Anaphylaxis due to the MMR vaccine on or before the child’s second birthday.\n- All of the following anytime on or before the child’s second birthday (on the same or different date of service):\n - History of measles.\n - History of mumps.\n - History of rubella.\n\nHiB\nChildren with either of the following meet criteria on or before the child’s second birthday:\n- At least three HiB vaccinations, with different dates of service. Do not count a vaccination administered prior to 42 days after birth.\n- Anaphylaxis due to the HiB vaccine.\n\nHep B\nChildren with any of the following on or before the child’s second birthday meet criteria:\n- At least three hepatitis B vaccinations, with different dates of service.\n - One of the three vaccinations can be a newborn hepatitis B vaccination during the eight-day period that begins on the date of birth and ends seven days after the date of birth. For example, if the member’s date of birth is December 1, the newborn hepatitis B vaccination must be on or between December 1 and December 8.\n- Anaphylaxis due to the hepatitis B vaccine.\n- History of hepatitis B illness.\n\nVZV\nChildren with any of the following meet criteria:\n- At least one VZV vaccination, with a date of service on or between the child’s first and second birthdays.\n- Anaphylaxis due to the VZV vaccine on or before the child’s second birthday.\n- History of varicella zoster (e.g., chicken pox) illness on or before the child’s second birthday.\n\nPCV\nChildren with either of the following on or before the child’s second birthday meet criteria:\n- At least four pneumococcal conjugate vaccinations, with different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n- Anaphylaxis due to the pneumococcal vaccine.\n\nHep A\nChildren with any of the following meet criteria:\n- At least one hepatitis A vaccination, with a date of service on or between the child’s first and second birthdays.\n- Anaphylaxis due to the hepatitis A vaccine on or before the child’s second birthday.\n- History of hepatitis A illness on or before the child’s second birthday.\n\nRV\nChildren with any of the following meet criteria:\n- At least two doses of the two-dose rotavirus vaccine on different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n- At least three doses of the three-dose rotavirus vaccine on different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n- At least one dose of the two-dose rotavirus vaccine and at least two doses of the three-dose rotavirus vaccine, all on different dates of service, on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n- Anaphylaxis due to the rotavirus vaccine on or before the child’s second birthday.\n\nFlu\nChildren with either of the following on or before their second birthday meet criteria:\n- At least two influenza vaccinations, with different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 6 months (180 days) after birth.\n - One of the two vaccinations can be a Live Attenuated Influenza Vaccine (LAIV) vaccination administered on the child’s second birthday. Do not count a LAIV vaccination administered before the child’s second birthday.\n- Anaphylaxis due to the influenza vaccine.", "eMeasureUuids": { "initialPopulationUuid": "1BF7CD8D-B257-401E-ABF7-252DABA0D209", "denominatorUuid": "74892E72-0D00-4391-8577-5C387410C89D", "numeratorUuid": "511390B8-515A-4CA0-B52D-68DBD9ABE83C", "denominatorExclusionUuid": "403C825E-43CA-410D-A105-62A9E7058BD0" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS1188v1", "eMeasureUuid": "2c928082-86db-6718-0186-e6f01b5c037f", "strata": [ { "description": "Patients who were tested for each of the following at least once during the measurement period: syphilis, gonorrhea, and chlamydia", "eMeasureUuids": { "initialPopulationUuid": "324CDEA8-BCC3-4FCF-9C50-F761C0472647", "denominatorUuid": "F5D38923-28DF-4D69-8AEF-D815FEDD5D42", "numeratorUuid": "0A3BBBBD-6151-4113-96F5-4E8F194D19AF" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS122v12", "eMeasureUuid": "2c928084-83d3-1b44-0183-eb75dc8a03db", "strata": [ { "description": "Patients whose most recent HbA1c level (performed during the measurement period) is >9.0% or is missing, or was not performed during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "F09F8D18-F787-46EA-8791-3D3EF50A4C72", "denominatorUuid": "66505C6C-AAB0-4232-B0CA-15FB438090F4", "numeratorUuid": "95BCB9D4-86A8-43C1-BE29-7440A2ECE294", "denominatorExclusionUuid": "6AD9B271-BBB4-4BB6-95B1-D1A7E50D812F" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS124v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6bf198d120d0", "strata": [ { "description": "Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:\n- Cervical cytology performed during the measurement period or the two years prior to the measurement period for women 24-64 years of age by the end of the measurement period\n\n- Cervical human papillomavirus (HPV) testing performed during the measurement period or the four years prior to the measurement period for women who are 30 years or older at the time of the test", "eMeasureUuids": { "initialPopulationUuid": "3AF3235F-EDCA-4EB9-827E-71987F79CDD4", "denominatorUuid": "E4C30FAC-4E01-4B7A-9765-427708423275", "numeratorUuid": "98980303-5719-4B0A-89C8-A284E41FD6E7", "denominatorExclusionUuid": "1C74FAE8-2761-49B9-803B-226477179DB1" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS125v12", "eMeasureUuid": "2c928084-8211-3ece-0182-c771f89f2ff3", "strata": [ { "description": "Women with one or more mammograms any time on or between October 1 two years prior to the measurement period and the end of the measurement period", "eMeasureUuids": { "initialPopulationUuid": "43AA0269-D0DC-41E1-AF57-DEC8865CEFB2", "denominatorUuid": "AE17C979-C086-4FD0-AD65-6F91B1BA6DB7", "numeratorUuid": "45BBBED1-06A2-4381-837F-95755D2C0D72", "denominatorExclusionUuid": "7E0603B0-134D-45E7-97AE-C3E1E35EBA05" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS128v12", "eMeasureUuid": "2c928084-83d3-1b44-0183-ec9f5639051f", "strata": [ { "description": "Patients who have received antidepressant medication for at least 84 days (12 weeks) of continuous treatment beginning on the IPSD through 114 days after the IPSD (115 total days).", "eMeasureUuids": { "initialPopulationUuid": "5C0C2E55-560F-42C1-85E0-2CE36D7F48B4", "denominatorUuid": "23702C38-4048-438D-BCFC-5B507AB0E058", "numeratorUuid": "D1230E54-3ED7-4E37-9BD9-14BD987A89CD", "denominatorExclusionUuid": "3810F33A-CC55-4949-9DE6-0CD5CCF31723" } }, { "description": "Patients who have received antidepressant medications for at least 180 days (6 months) of continuous treatment beginning on the IPSD through 231 days after the IPSD (232 total days).", "eMeasureUuids": { "initialPopulationUuid": "7FE1D093-EFE8-4A37-BB62-F54FE320ABD1", "denominatorUuid": "2C0FDE5F-C7A5-43A4-9AB2-EF1ED5AF9017", "numeratorUuid": "2707A6AA-72DE-4D68-B619-775D8715A7BE", "denominatorExclusionUuid": "C25C172D-A823-4ADD-AABD-4BF11ABA3928" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS129v13", "eMeasureUuid": "2c928082-82cb-a3f5-0182-cc6b3d5600b0", "strata": [ { "description": "Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer", "eMeasureUuids": { "initialPopulationUuid": "8EB5DA27-ADE5-4E8E-8C4F-934F0F8B8C63", "denominatorUuid": "36E7BB9E-4573-441A-B684-F680D2AF5022", "numeratorUuid": "F57519D7-4AAE-4020-8239-A8C9DE7E59EA", "denominatorExceptionUuid": "C8885C12-E38D-4B28-A2B5-86867AB94660" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS130v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6bf2944520dc", "strata": [ { "description": "Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: \n- Fecal occult blood test (FOBT) during the measurement period\n- Stool DNA (sDNA) with FIT test during the measurement period or the two years prior to the measurement period\n- Flexible sigmoidoscopy during the measurement period or the four years prior to the measurement period\n- CT Colonography during the measurement period or the four years prior to the measurement period\n- Colonoscopy during the measurement period or the nine years prior to the measurement period", "eMeasureUuids": { "initialPopulationUuid": "CE7E7820-62A0-430C-93D4-36F096BC66F1", "denominatorUuid": "01CFAAD2-55BE-4F1F-AF0D-58C11583FEFC", "numeratorUuid": "D01C8F72-6AA1-4DF9-8458-29DE8F10D4FE", "denominatorExclusionUuid": "6B6E3E45-86AA-4AEC-917D-6A7D5D452513" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS131v12", "eMeasureUuid": "2c928084-83d3-1b44-0183-eb5b615a038d", "strata": [ { "description": "Patients with an eye screening for diabetic retinal disease. This includes diabetics who had one of the following:\n- Diabetic with a diagnosis of retinopathy in any part of the measurement period and a retinal or dilated eye exam by an eye care professional in the measurement period\n- Diabetic with no diagnosis of retinopathy in any part of the measurement period and a retinal or dilated eye exam by an eye care professional in the measurement period or the year prior to the measurement period", "eMeasureUuids": { "initialPopulationUuid": "122474BF-173C-4993-A45D-E8ACA5FC3D46", "denominatorUuid": "3B8410A4-573B-43A5-A739-505204CBF25B", "numeratorUuid": "0BE93516-A3B7-44E5-AAB3-0B2EA25EAE08", "denominatorExclusionUuid": "09957F27-2BD4-47FA-AAF4-201FD6F76E90" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS133v12", "eMeasureUuid": "2c928083-8651-08a3-0186-be2f15911815", "strata": [ { "description": "Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery", "eMeasureUuids": { "initialPopulationUuid": "160359D2-7F76-4E14-A48F-6A3C26362ADC", "denominatorUuid": "33277593-C9A1-4604-AC41-9E924C3ACB88", "numeratorUuid": "8692F7ED-0E83-4A5E-A9A4-F60FF5DA2176", "denominatorExclusionUuid": "6A29982C-BF52-4BC1-9DCF-C120B35ED292" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS135v12", "eMeasureUuid": "2c928082-86db-6718-0186-ec6666280586", "strata": [ { "description": "Patients who were prescribed or already taking ACE inhibitor or ARB or ARNI therapy during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "3BBD33AA-ACDC-4D08-A22D-2B640B3BAC55", "denominatorUuid": "D5EC2146-2734-4AEA-941E-73954FBC0CAC", "numeratorUuid": "91C32273-EEF9-4557-992A-3C5DA994B1A5", "denominatorExceptionUuid": "EED321A6-8960-4A3E-84C8-0E9F06919DC2", "denominatorExclusionUuid": "F269B9AD-04EE-4129-9B20-81DD1B1A0FAA" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS136v13", "eMeasureUuid": "2c928084-8211-3ece-0182-1de98c500310", "strata": [ { "description": "Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase.", "eMeasureUuids": { "initialPopulationUuid": "9B70E808-0E6B-44FB-AC46-0548A1E409DE", "denominatorUuid": "886B4ABD-BEB6-43DC-90AE-C529F5E07B47", "numeratorUuid": "FD0D1365-F405-4A66-9B7A-2ABE64033E8A", "denominatorExclusionUuid": "00B7D640-5DD7-41D1-BF47-B95A2C19B6D7" } }, { "description": "Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase, and at least two follow-up visits on different dates of service during the 31-300 days after the IPSD.", "eMeasureUuids": { "initialPopulationUuid": "72606B57-2F1C-40B4-9655-F691A594A611", "denominatorUuid": "F6EA0497-C79C-4722-838F-528A8635F1BE", "numeratorUuid": "0DFDC593-66E3-4532-9F27-6C5C6C947EE5", "denominatorExclusionUuid": "CD78A07D-8D5B-4E22-B05E-9A569B2FC375" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS137v12", "eMeasureUuid": "2c928084-82ea-d7c5-0182-ec98d1c20129", "strata": [ { "description": "Initiation of treatment includes either an intervention or medication for the treatment of SUD within 14 days of the new SUD episode", "eMeasureUuids": { "initialPopulationUuid": "703CE63C-957D-4214-AAEF-6DE14AE91E80", "denominatorUuid": "CBB623A8-C906-4712-983B-A532F984C2E9", "numeratorUuid": "D2C1C13B-097B-4210-922F-7AAE70F50F46", "denominatorExclusionUuid": "A6BAB6F7-FEB7-465E-8669-B48C2A05A003" } }, { "description": "Engagement in ongoing SUD treatment within 34 days of initiation includes:", "eMeasureUuids": { "initialPopulationUuid": "6492A3E6-D8C8-40A1-B280-909DB3436D1E", "denominatorUuid": "1F384AE6-DC33-4464-A743-D883C75BDCE9", "numeratorUuid": "3C89FB2F-3335-4384-8F25-FB58A1B00AE3", "denominatorExclusionUuid": "353DB0FA-5117-40DD-A989-8FA220D184BC" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS138v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-14b6afcb0cc9", "strata": [ { "description": "Patients who were screened for tobacco use at least once during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "8B63E323-F12A-4174-9EB2-FB64A7285C99", "denominatorUuid": "1AF6FBFC-F6BA-4042-BA31-66127FE4CA0A", "numeratorUuid": "718DDAB1-A99D-40B2-9F33-DB0AA5D464A7", "denominatorExclusionUuid": "07496BE4-AE52-47FA-8076-337EB1FB8307" } }, { "description": "Patients who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period", "eMeasureUuids": { "initialPopulationUuid": "F65684D1-43BD-440C-AF43-93F592672854", "denominatorUuid": "26CCD818-574C-4325-9BA8-3992BAB67070", "numeratorUuid": "EB24BBAB-E314-4A42-8329-E559D0AADAA6", "denominatorExclusionUuid": "076BA627-E3B6-40C8-ABA8-9FDE6FF11070" } }, { "description": "Patients who were screened for tobacco use at least once during the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as a tobacco user", "eMeasureUuids": { "initialPopulationUuid": "9434749C-2953-46FF-9C2F-393DDAA96365", "denominatorUuid": "7461BAC8-F77B-44BF-ADE6-ED9F599CF3FB", "numeratorUuid": "FAAEB19D-EE61-4F58-970C-933F47B38E34", "denominatorExclusionUuid": "5BC836CA-2EC0-417B-8D55-182CEF941994" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS139v12", "eMeasureUuid": "2c928084-83d3-1b44-0183-eca0b20c052a", "strata": [ { "description": "Patients who were screened for future fall risk at least once within the measurement period", "eMeasureUuids": { "initialPopulationUuid": "37671229-ED87-4DA8-A6AC-6F582490677B", "denominatorUuid": "34FE0E39-10FD-4FDE-8153-AA2BA305B932", "numeratorUuid": "BA0D192C-510B-4426-AA90-0835DF0F5F91", "denominatorExclusionUuid": "88313CAE-FC20-4EA6-9375-0F5CB0106E63" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS142v12", "eMeasureUuid": "2c928084-83d3-1b44-0183-e7a92aa602f4", "strata": [ { "description": "Patients with documentation, at least once within the measurement period, of the findings of the dilated macular or fundus exam via communication to the physician who manages the patient's diabetic care", "eMeasureUuids": { "initialPopulationUuid": "638B2963-BA05-46A1-8B77-3048996550D5", "denominatorUuid": "4F2B95F6-6C7C-4F94-B179-F287728137B5", "numeratorUuid": "C4A0619A-6D14-4730-9962-709A3A1C5115", "denominatorExceptionUuid": "8EF9060A-EA84-4161-A32F-24A93D72D49C" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS143v12", "eMeasureUuid": "2c928082-853a-caf8-0185-f403c54b1a15", "strata": [ { "description": "Patients who have an optic nerve head evaluation during one or more visits within 12 months", "eMeasureUuids": { "initialPopulationUuid": "42ED6272-F01E-4EED-A790-390F3EEE3062", "denominatorUuid": "8BACF708-E10D-4614-8614-C2A5E97884D6", "numeratorUuid": "50A864CE-3A7A-41CE-93D5-DA29517AF2F5", "denominatorExceptionUuid": "804B8FB4-9462-4A13-91B5-9B9FFED6EF99" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS144v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-65e9c0061ec1", "strata": [ { "description": "Patients who were prescribed or already taking beta-blocker therapy during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "BC5D30AA-8AA4-4BA6-9FBE-B52D47CAF292", "denominatorUuid": "F2435FA0-0AF1-4A64-BB27-4E7ED13F387B", "numeratorUuid": "D997534A-AF2A-4AEE-9EFC-358EB0273EDB", "denominatorExceptionUuid": "A3ED0DA1-60C2-4D42-BF86-EDEF350CD369", "denominatorExclusionUuid": "C7CFF7D2-0A86-4FB1-BBA7-2A91E65262C8" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS145v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-622192411e05", "strata": [ { "description": "Patients with left ventricular systolic dysfunction (LVEF <=40%)", "eMeasureUuids": { "initialPopulationUuid": "2E452C4A-C782-4373-AB54-646521DCDDEE", "denominatorUuid": "901D3C9A-DB42-4A92-9E78-2693F6EEDA99", "numeratorUuid": "DBA0383C-B6EE-4ACC-A44F-9A11E0C4C33F", "denominatorExceptionUuid": "223FC84C-A50A-4460-92B5-3808D89FF2C9" } }, { "description": "Patients with a prior (within the past 3 years) myocardial infarction", "eMeasureUuids": { "initialPopulationUuid": "F0F58CC7-7DC0-4BC2-AD55-4B92696A4501", "denominatorUuid": "C0A53EC4-5324-4C8B-B7E1-BA52F9D3D10C", "numeratorUuid": "A3DAC3E6-BAAF-4A42-89E6-8AC8FAA71E68", "denominatorExceptionUuid": "4315CAB0-73F3-4756-A9F2-DDADD376D77E" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS146v12", "eMeasureUuid": "2c928084-8389-524e-0183-cd90c213122b", "strata": [ { "description": "A group A streptococcus test in the seven-day period from three days prior to the episode date through three days after the episode date", "eMeasureUuids": { "initialPopulationUuid": "3CB297BD-CF52-44ED-85C1-F2D22C338BF3", "denominatorUuid": "B9860D63-1954-4AAD-A6BC-7A3996B1914B", "numeratorUuid": "3A230D4E-2D2A-44C4-8693-140BD8752334", "denominatorExclusionUuid": "AA5B2690-F5A3-440F-84B6-F7306C9C7467" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS149v12", "eMeasureUuid": "2c928082-86db-6718-0186-ec153eff0520", "strata": [ { "description": "Patients for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period", "eMeasureUuids": { "initialPopulationUuid": "673EA403-B47A-4D1B-AC0E-21433ECB2F6F", "denominatorUuid": "0560F410-479D-4AAC-8637-C60A33BD9EBA", "numeratorUuid": "A0400F83-1D8C-4EAE-8477-970F25C28916", "denominatorExceptionUuid": "ECB48742-57C1-44DA-9EAF-14FC0BC55F9B" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS153v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6bf2f90320e6", "strata": [ { "description": "Women with at least one chlamydia test during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "34EA6AAA-3940-444F-AF54-40F61808E3A7", "denominatorUuid": "C74AE380-0593-4D95-BFD6-D71D3AF4AC8D", "numeratorUuid": "8113EBC1-FE78-4EEF-BD38-5A7EF93EF90F", "denominatorExclusionUuid": "C5EEC624-E6B5-4197-BF65-A932BC9D7CEA" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS154v12", "eMeasureUuid": "2c928084-8389-524e-0183-c8d7a6700f02", "strata": [ { "description": "URI episodes without a prescription for antibiotic medication on or three days after the outpatient visit, telephone visit, online assessment, observation stay or emergency department visit for an upper respiratory infection", "eMeasureUuids": { "initialPopulationUuid": "83DB196F-463B-4E77-ABC4-7B38F0C60D36", "denominatorUuid": "766AC88F-A02D-42E1-B34C-7BFB2874A824", "numeratorUuid": "EE960FF9-ED6B-49E8-A1CC-D0C93513355B", "denominatorExclusionUuid": "8DABD0C9-3DE6-4221-9F84-0E2EB872075F" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS155v12", "eMeasureUuid": "2c928084-83d3-1b44-0184-62ae126a1f0f", "strata": [ { "description": "Patients who had a height, weight and body mass index (BMI) percentile recorded during the measurement period.", "eMeasureUuids": { "initialPopulationUuid": "9167639A-D698-40C4-9C15-2EB0EFD3A78C", "denominatorUuid": "6B3A0F3B-7918-4C92-9554-4CE8BD22D85A", "numeratorUuid": "4044128B-08AC-4F62-9B34-DC2D8C5BCF75", "denominatorExclusionUuid": "A212CB41-A5DE-4B48-BF10-9D8A5998C777" } }, { "description": "Patients who had counseling for nutrition during the measurement period.", "eMeasureUuids": { "initialPopulationUuid": "989F58BC-AA7D-4B84-A65D-733B2BC91988", "denominatorUuid": "D75CAE28-A482-4365-8710-D18E03F20009", "numeratorUuid": "5405AB82-FB25-4751-A79B-6B9118D38721", "denominatorExclusionUuid": "17E77543-B68D-48E2-98DE-CA35F6984CB4" } }, { "description": "Patients who had counseling for physical activity during the measurement period.", "eMeasureUuids": { "initialPopulationUuid": "18A31343-FDAD-46BF-8E7B-F3EC2A3A5A24", "denominatorUuid": "2D2DD45E-43A8-494D-AFBA-EB888DC127D1", "numeratorUuid": "4A2A1F08-2CB8-494B-BC02-1773CBB9D820", "denominatorExclusionUuid": "5D515304-DA28-4F12-8F36-DF1ED7C640FA" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS156v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6293dcff1e19", "strata": [ { "description": "Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class.", "eMeasureUuids": { "initialPopulationUuid": "1D3F49A0-F7A0-4E55-B953-DB944A082814", "denominatorUuid": "4960C71F-4317-4A3A-85FF-A0144EEFCBE5", "numeratorUuid": "6CC7B742-D134-49C1-95B9-35CA2E96D754", "denominatorExclusionUuid": "DA1FD97B-4CD9-4BFD-9DEA-60146DCACF2D" } }, { "description": "Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class, except for appropriate diagnoses.", "eMeasureUuids": { "initialPopulationUuid": "07BFBC59-A849-4BA4-8998-9C7876573D4E", "denominatorUuid": "D17677FA-08EB-4729-B22D-33874A21216F", "numeratorUuid": "3ED7845E-19B0-476B-9650-D439EB4E5900", "denominatorExclusionUuid": "8EF5897B-E8CD-46AB-B5E3-5E543E3A47FC" } }, { "description": "Total rate (the sum of the two numerators divided by the denominator, deduplicating for patients in both numerators).", "eMeasureUuids": { "initialPopulationUuid": "3233FCCF-FA30-41B3-8A3D-13B0E3F2FC97", "denominatorUuid": "4323442F-0C78-4BE2-B2D8-982A5BD89A4F", "numeratorUuid": "6300B4BC-C38E-41D4-A904-1D9D76964F98", "denominatorExclusionUuid": "BAB26534-B8DA-415B-8AC6-7C87CC4BCDA9" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS157v12", "eMeasureUuid": "2c928084-8389-524e-0183-d1b67f3a1388", "strata": [ { "description": "Visits for patients with a diagnosis of cancer who are currently receiving chemotherapy", "eMeasureUuids": { "initialPopulationUuid": "0271EF2B-26A3-4672-A697-F227D294C5E8", "denominatorUuid": "E0C4BF62-6A49-4CFF-A215-49C1E1D966F1", "numeratorUuid": "DF2CFD3B-1B2E-45C0-A2C3-F048317ECCE6" } }, { "description": "Visits for patients with a diagnosis of cancer who are currently receiving radiation therapy", "eMeasureUuids": { "initialPopulationUuid": "05739862-79A6-4DEC-BD34-0ADE00ED65A8", "denominatorUuid": "5E21A436-94F8-47BD-BD09-C1F94F1C347D", "numeratorUuid": "81010375-6D7E-42D3-89F7-9FD33A231FD8" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS159v12", "eMeasureUuid": "2c928082-86db-6718-0187-0ad80afa0a7e", "strata": [ { "description": "Adolescent patients 12 to 17 years of age and adult patients 18 years of age and older who achieved remission at twelve months as demonstrated by the most recent twelve month (+/- 60 days) PHQ-9 or PHQ-9M score of less than five", "eMeasureUuids": { "initialPopulationUuid": "E4E92400-0CE1-403C-818D-EF5C25A952AA", "denominatorUuid": "4B7B1714-FE42-40EB-A652-7C077636A8BF", "numeratorUuid": "8A5DE292-E5E6-45CE-99C6-22E6F8E688E4", "denominatorExclusionUuid": "4539BAD0-93C8-4606-B167-91086446F8D8" } } ], "metricType": "multiPerformanceRate" }, { "eMeasureId": "CMS165v12", "eMeasureUuid": "2c928085-806c-39a2-0180-7092fa9b0145", "strata": [ { "description": "Patients whose most recent blood pressure is adequately controlled (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "F348D767-1BDE-41AB-884D-5F0E19093980", "denominatorUuid": "3E0D40B3-64FC-4998-B371-34978D033116", "numeratorUuid": "24803F44-C643-45C7-A2A5-4C58BD540579", "denominatorExclusionUuid": "95E1480E-8B61-4777-865D-B2A1D6525E1A" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS177v12", "eMeasureUuid": "2c928084-82ea-d7c5-0182-ff64c38d094f", "strata": [ { "description": "Patient visits with an assessment for suicide risk", "eMeasureUuids": { "initialPopulationUuid": "2A6F66CE-9C98-471E-93C7-5C8A67261CDD", "denominatorUuid": "913060C1-BAAB-456E-99C5-A6B9662CC06E", "numeratorUuid": "9C5E92E5-D8B5-4DC9-9021-195E264FB2E0" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS22v12", "eMeasureUuid": "2c928082-86db-6718-0187-09773acf09d0", "strata": [ { "description": "Patient visits where patients were screened for high blood pressure AND have a recommended follow-up plan documented, as indicated, if the blood pressure is elevated or hypertensive", "eMeasureUuids": { "initialPopulationUuid": "F071FE72-E624-401F-BEA1-93B16E883386", "denominatorUuid": "8A30830D-9606-4AF2-836C-40EC4CF3A4D4", "numeratorUuid": "B9122899-0E15-4BB1-A049-B5038D708AD2", "denominatorExceptionUuid": "5AC75B0E-E6A1-419E-8F46-1F49755BCC09", "denominatorExclusionUuid": "DEBE98FB-5956-4BFD-8EA4-D14B15E53BE1" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS249v6", "eMeasureUuid": "2c928084-82ea-d7c5-0183-204c9a0c1112", "strata": [ { "description": "Female patients who received an order for at least one DXA scan in the measurement period", "eMeasureUuids": { "initialPopulationUuid": "CBBBA0E8-63BC-4E0F-BFA4-A28A95C1527D", "denominatorUuid": "EEEAFBC3-AAFB-417C-81BD-9034CFE7F5E1", "numeratorUuid": "769B6087-B19F-4FE1-88C8-C4519D1A6674", "denominatorExclusionUuid": "F5F72298-D99A-4669-A1C1-F6851CCE3303", "numeratorExclusionUuid": "06BE45AA-51B5-4E8E-BDBF-4C0E68E7B5CC" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS2v13", "eMeasureUuid": "2c928083-8651-08a3-0186-c82995a91d28", "strata": [ { "description": "Patients screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized tool AND if positive, a follow-up plan is documented on the date of or up to two days after the date of the qualifying encounter", "eMeasureUuids": { "initialPopulationUuid": "AD83208C-1313-401E-BB62-ABCCE0982B49", "denominatorUuid": "696066C7-C558-4849-A325-A3CDDB58CF8F", "numeratorUuid": "E2557B71-1B97-413F-BE26-2B037E4D590B", "denominatorExceptionUuid": "FBA7B9D9-8588-4CB2-AB72-642CBD980334", "denominatorExclusionUuid": "E52F7FAE-96D9-417A-8538-6E3DB4A31D7A" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS314v1", "eMeasureUuid": "2c928082-86db-6718-0187-03d1acee0811", "strata": [ { "description": "Patients with a last HIV viral load test result of less than 200 copies/mL during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "F8EEABA6-5F4A-435A-B0A5-25BB3D24205D", "denominatorUuid": "1633252F-B022-4E7D-8DDB-3D439A18AEE2", "numeratorUuid": "3723189C-3247-428F-AF1E-D2E510D0A9DB" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS347v7", "eMeasureUuid": "2c928082-82cb-a3f5-0182-cc688be40080", "strata": [ { "description": "All patients who were previously diagnosed with or currently have a diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD), including an ASCVD procedure", "eMeasureUuids": { "initialPopulationUuid": "0B4F91D7-B2F9-48AF-A3ED-9115908DCAFE", "denominatorUuid": "34D89E97-4B99-43BB-97C7-C071F0DF971A", "numeratorUuid": "D7F7EDC4-8930-4656-96C5-818874EDA005", "denominatorExceptionUuid": "01D44136-D906-4907-95C4-08D6CE12621E", "denominatorExclusionUuid": "26B642A2-FA54-4CDD-9777-340A16FCB119" } }, { "description": "Patients aged 20 to 75 years who have ever had a low-density lipoprotein cholesterol (LDL-C) level >= 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia", "eMeasureUuids": { "initialPopulationUuid": "45432B7C-8E52-42C9-9901-EBC06AA312EA", "denominatorUuid": "6498FD8C-CC34-4A75-97BB-479ED9C7E7B2", "numeratorUuid": "3768636A-6914-4E99-A1FF-86985EA906CE", "denominatorExceptionUuid": "295A9E4F-F784-4DE5-B228-8094E589B6EB", "denominatorExclusionUuid": "0C5DCCA9-17F2-41FC-9898-2E69F6BD4D52" } }, { "description": "Patients aged 40-75 years with a diagnosis of diabetes", "eMeasureUuids": { "initialPopulationUuid": "A1AB27A9-7C38-44A6-9FD5-4CCAD4015D2F", "denominatorUuid": "B84D1E69-BE12-429B-94BB-C52A6C7C05D1", "numeratorUuid": "AA438B03-6489-404B-B9E1-519A3CBBA075", "denominatorExceptionUuid": "A07A4226-5C2F-46CE-AE94-4DC932D1FC2E", "denominatorExclusionUuid": "DC9CE27C-94EF-4D4D-B2B9-20BB47ECB959" } }, { "description": "Patients aged 40 to 75 with a 10-year ASCVD risk score of >= 20 percent", "eMeasureUuids": { "initialPopulationUuid": "8B574B6B-8D8A-4E82-B1D5-193593C79E03", "denominatorUuid": "DCD01DD8-1B0B-4BDA-A69C-F928346A6B51", "numeratorUuid": "327F02A6-9AB0-4B06-8CD9-EB8805A6E344", "denominatorExceptionUuid": "BD48F0E9-0218-4381-94E1-6A12DF7BDF68", "denominatorExclusionUuid": "B0A97297-2AF3-414F-80A8-8DBA5D14A604" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS349v6", "eMeasureUuid": "2c928082-86db-6718-0187-0a05d6d40a25", "strata": [ { "description": "Patients with documentation of an HIV test performed on or after their 15th birthday and before their 66th birthday", "eMeasureUuids": { "initialPopulationUuid": "67CF99E8-D390-44E4-A844-A1156D58DAF7", "denominatorUuid": "BB5D4991-83D5-4071-8F96-EE7FE11968F1", "numeratorUuid": "1E6C29F5-22B3-45CC-B11E-7DF0B25E86C1", "denominatorExceptionUuid": "4133AB59-F9DC-4C0F-A697-C2AB4C160769", "denominatorExclusionUuid": "FA1DD323-C493-46B2-9A7B-C4109109FC7A" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS50v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-41af6b41186d", "strata": [ { "description": "Number of patients with a referral on or before October 31, for which the referring clinician received a report from the clinician to whom the patient was referred", "eMeasureUuids": { "initialPopulationUuid": "76338B6C-C26C-4190-BAF1-0AAC5873C7B9", "denominatorUuid": "E846226B-FB7D-4B3C-8C3E-EC0FC4509C5F", "numeratorUuid": "256DDBEE-BDFA-4BEC-A777-448CFC17938E" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS56v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6bd4e33420bd", "strata": [ { "description": "Patients with patient-reported functional status assessment results (i.e., Veterans RAND 12-item health survey [VR-12], Patient-Reported Outcomes Measurement Information System [PROMIS]-10-Global Health, Hip Disability and Osteoarthritis Outcome Score [HOOS], HOOS Jr.) in the 90 days prior to or on the day of the primary THA procedure, and in the 300 - 425 days after the THA procedure", "eMeasureUuids": { "initialPopulationUuid": "AF4C1C0E-79D7-4693-ACB8-6FACDCEEF0D4", "denominatorUuid": "60759161-5DB6-4E1B-8D07-32A5561AE0C4", "numeratorUuid": "AA9FBD3C-49EC-4A9E-BDD5-65F454BC7416", "denominatorExclusionUuid": "A640731E-3B26-4662-A243-C1BED87544AF" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS645v7", "eMeasureUuid": "2c928084-82ea-d7c5-0183-851958a525c2", "strata": [ { "description": "Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment", "eMeasureUuids": { "initialPopulationUuid": "4653DDD0-4E47-46F8-91EC-754DB709FD5B", "denominatorUuid": "7AF6325B-6BE7-4E06-A8EB-3CE504E877A8", "numeratorUuid": "43D18B6F-9887-41EB-B4EC-0A391BAAEE41", "denominatorExceptionUuid": "115003E3-848E-405F-A3FB-AA1B79CE174A" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS646v4", "eMeasureUuid": "2c928084-82ea-d7c5-0183-80636c102400", "strata": [ { "description": "Intravesical Bacillus-Calmette Guerin (BCG) instillation for initial dose or series:\nBCG is initiated within 6 months of the bladder cancer staging", "eMeasureUuids": { "initialPopulationUuid": "CA862BB0-8855-448D-9BE7-01C5B7CF208D", "denominatorUuid": "F785197D-F7C7-4146-883B-204B75CC0738", "numeratorUuid": "03D37613-A20E-44BD-B417-724A97F1A95F", "denominatorExceptionUuid": "BB1A3D97-EF9F-4F2E-8574-2A43A12B045F", "denominatorExclusionUuid": "5C4B56EC-9420-448F-BD0C-1BBF0D0D00B4" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS68v13", "eMeasureUuid": "2c928082-86db-6718-0187-0b4977140ad5", "strata": [ { "description": "Eligible clinician attests to documenting, updating, or reviewing the patient's current medications using all immediate resources available on the date of the encounter", "eMeasureUuids": { "initialPopulationUuid": "018818BA-BAEE-4F63-B345-0ECF647B7580", "denominatorUuid": "F0F5F489-3AE0-4128-A3D3-7427B5F333A4", "numeratorUuid": "A65C0BE1-19D2-40E5-910D-9B95960C4B6C", "denominatorExceptionUuid": "294E02A5-FBA5-4863-B215-D25B396C3E79" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS69v12", "eMeasureUuid": "2c928082-82cb-a3f5-0182-cc6968e30090", "strata": [ { "description": "Patients with a documented BMI during the encounter or during the measurement period, AND when the BMI is outside of normal parameters, a follow-up plan is documented during the encounter or during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "AA4FB3BF-5710-420F-9A5C-DE12B49C6976", "denominatorUuid": "06FBEA08-FCFF-4A81-AD0F-944E3905A8D2", "numeratorUuid": "5C891031-333A-4BF2-9EE6-98657DB3D7B0", "denominatorExceptionUuid": "9D67E64C-4F4E-4A49-B7F9-E4CC25465AE4", "denominatorExclusionUuid": "D28BB99A-13F9-4789-9890-0EE2A303E46A" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS74v13", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6ba7b54220a8", "strata": [ { "description": "Children who receive two fluoride varnish applications on different days during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "6AEE2ABF-4E94-4EDC-ABF8-E93B14CEFC0B", "denominatorUuid": "C82B7932-A51A-4282-AD2F-60124341C172", "numeratorUuid": "E50E2341-598D-412C-912B-3C837E59D64E", "denominatorExclusionUuid": "0A8E4FD6-44FF-4442-A51A-9AF66C1EF353" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS75v12", "eMeasureUuid": "2c928084-82ea-d7c5-0183-6d3507282122", "strata": [ { "description": "Children who had a diagnosis of cavities or decayed teeth in any part of the measurement period", "eMeasureUuids": { "initialPopulationUuid": "4BA69C4A-51FB-4A29-A0D6-D450DFECD3B6", "denominatorUuid": "035785B3-DB35-4CEB-81F3-888AEE341510", "numeratorUuid": "7132A615-8EB6-48E5-9747-2C617C29E2D1", "denominatorExclusionUuid": "9E3A0D44-7413-468D-8AA8-F95836EB45A0" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS771v5", "eMeasureUuid": "2c928084-82ea-d7c5-0183-8070b188242a", "strata": [ { "description": "Patients with a documented improvement of at least 3 points in their urinary symptom score during the measurement period", "eMeasureUuids": { "initialPopulationUuid": "B22A5E42-6D6D-4245-A055-93C43CBE6931", "denominatorUuid": "01C7E97C-2622-4313-B83F-A87E29E17D10", "numeratorUuid": "B8575953-F61E-4514-B517-1DC9481F6361", "denominatorExclusionUuid": "D8618A69-3B77-4E4A-975B-F08FD2DA0306" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS90v13", "eMeasureUuid": "2c928084-8389-524e-0183-c80f9e480dff", "strata": [ { "description": "Patients with patient-reported functional status assessment results (i.e., Veterans RAND 12-item health survey [VR-12]; VR-36; Kansas City Cardiomyopathy Questionnaire [KCCQ]; KCCQ-12; Minnesota Living with Heart Failure Questionnaire [MLHFQ]; Patient-Reported Outcomes Measurement Information System [PROMIS]-10 Global Health; PROMIS-29) present in the EHR within two weeks before or during the initial FSA encounter and results for the follow-up FSA at least 30 days but no more than 180 days after the initial FSA", "eMeasureUuids": { "initialPopulationUuid": "FA9EF028-5532-437D-9125-4187BF72E952", "denominatorUuid": "3BDFDBDD-CEBF-4C34-8AA7-8D65A324F4B1", "numeratorUuid": "91550F78-0296-4B2A-996C-0B9F51B9FAF3", "denominatorExclusionUuid": "CC8028CF-86F0-4930-AB9F-475DA2370A5B" } } ], "metricType": "singlePerformanceRate" }, { "eMeasureId": "CMS951v2", "eMeasureUuid": "2c928082-84ce-8286-0185-30f50cd0190f", "strata": [ { "description": "Patients who received a kidney health evaluation defined by an eGFR AND uACR within the measurement period", "eMeasureUuids": { "initialPopulationUuid": "8949FAFC-6ADB-4499-AAC0-FD415D8167FC", "denominatorUuid": "14CF30C1-086C-4128-81AD-85D19BBEA671", "numeratorUuid": "36C34866-1126-4C38-827B-AA3FA4D34976", "denominatorExclusionUuid": "D4E27C5C-032A-448F-877C-71A1C44D478F" } } ], "metricType": "singlePerformanceRate" } ]